Maven Clinic
Reproductive healthcare is getting redesigned.
The latest: Fertility care company Maven Clinic closed a $125M investment, bringing its valuation to $1.7B and total funding to >$425M.
The raise will bolster its B2B fertility benefits platform, expanding end-to-end virtual care and scaling AI to complement its human-centered model.
With 2K+ clients across 175 countries—including corporations like Amazon and Microsoft—the company guides women’s reproductive health journey from preconception to postmenopause.
Mind the gap. Pregnant or not, employed women in the US still face $15B higher out-of-pocket healthcare costs per year than male peers. And treatment for infertility, affecting one in six people globally, can cost upwards of $50K.
Attracting investors, women-focused startups want to balance the scales.
- At-home hormone testing company Hertility received an investment from actress Emma Watson, surpassing $14M in total funding.
- Flora Fertility just closed a $1.5M pre-seed round for its direct-to-consumer fertility benefits platform.
- In June, B2B fertility benefits platform Progyny acquired German provider Apryl.
Takeaway: Along with fertility-tracking tech, clinics are reimagining care. Making progress, fertility benefits are becoming more common among employers, but reproductive health goes beyond family planning.
